FIELD: ophthalmology. SUBSTANCE: method involves introducing 15-20 μg of supernatant of cultures of stimulated autologous mononuclear cells of peripheral blood in amounts of 0.1-0.15 ml into vitreous body so as to approximate a model to clinical run at amotio retinae. EFFECT: improved model.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PROPHYLAXIS OF PROLIFERATIVE TRANSFORMATIONS IN VITREOUS BODY IN EXPERIMENT | 1991 |
|
RU2008861C1 |
METHOD OF PREVENTING COARSE CICATRIZATION OF CORNEA | 1991 |
|
RU2012890C1 |
IMMUNOSTIMULATING AGENT | 1998 |
|
RU2145500C1 |
METHOD OF ACUTE PNEUMONIA THERAPY | 1995 |
|
RU2118159C1 |
METHOD FOR MODELING PROLIFERATIVE VITRORETINOPATHY | 1998 |
|
RU2161335C2 |
METHOD OF THERAPY OF CHRONIC TONSILLITIS AND PHARYNGITIS | 1996 |
|
RU2123362C1 |
METHOD FOR PERFORMING CHRONIC SINUSITIS THERAPY | 1998 |
|
RU2164422C2 |
METHOD OF POLLINOSIS THERAPY | 1996 |
|
RU2139742C1 |
METHOD FOR PROPHYLAXIS OF COMPLICATIONS AFTER EXTRACTING CATARACT | 1993 |
|
RU2085158C1 |
METHOD OF PATIENT-SPECIFIC IMMUNOTHERAPY | 2009 |
|
RU2414228C1 |
Authors
Dates
1994-03-15—Published
1991-06-26—Filed